数据表1:肝细胞癌预后分层分析中DNA损伤响应与修复相关基因对特征的识别

肝细胞癌DNA损伤响应与修复相关基因对预后分层研究的数据表,基于TCGA等mRNA表达与临床数据构建23个基因对预后特征。

NIAID Data Ecosystem
浏览 12
基因组DNA damage response and repairhepatocellular carcinomaprognosisHBVchemotherapy
DataSheet1_Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.docx

基本信息

模态
基因组
大小
0.001919825 GB
许可
CC BY 4.0
创建/更新时间
2026-10-17
版本
v1

资源简介

数据表1:肝细胞癌预后分层分析中DNA损伤响应与修复相关基因对特征的识别

【一句话概览】

本数据集是 figshare 公开的组学数据集,收录 1 个文件、合计 1.92 MB,主题涵盖 DNA damage response and repair、hepatocellular carcinoma、prognosis、HBV、chemotherapy,可用于生物标志物发现与分子分型研究,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《DataSheet1_Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.docx》。配套论文《DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma》发表于 Frontiers in Immunology(2021),DOI:10.3389/fimmu.2021.676922。源站首次发布:2022-04-11。

【数据内容】

源站原始描述:Background: Nowadays, although the cause of hepatocellular carcinoma (HCC) mortality and recurrence remains at a high level, the 5-year survival rate is still very low. The DNA damage response and repair (DDR) pathway may affect HCC patients’ survival by influencing tumor development and therapeutic response. It is necessary to identify a prognostic DDR-related gene signature to predict the outcome of patients. Methods: Level 3 mRNA expression and clinical information were extracted from the TCG…

【数据结构与技术规格】

文件数 1 个,合计 1.92 MB。DataSheet1_Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carc.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,1.92 MB。数据集 DOI:10.3389/fphar.2022.857060.s001。

【主题与分类】

源站学科分类:Basic Pharmacology、Clinical Pharmacology and Therapeutics、Clinical Pharmacy and Pharmacy Practice、Pharmaceutical Sciences、Pharmacogenomics、Pharmacology。主题标签:DNA damage response and repair、hepatocellular carcinoma、prognosis、HBV、chemotherapy。

【适用方向】

组学数据适用于生物标志物发现与分子分型相关建模研究。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/DataSheet1_Identification_of_a_DNA_Damage_Response_and_Repair-Related_Gene-Pair_Signature_for_Prognosis_Stratification_Analysis_in_Hepatocellular_Carcinoma_docx/19573999

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Chen, Yi; Huang, Mengjia; Zhu, Junkai; Xu, Li; Cheng, Wenxuan; Lu, Xiaofan; et al. (2022). DataSheet1_Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.docx. Frontiers. Dataset

【使用注意】

· 源站最后修改于 2023-06-01,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "DataSheet1_Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carc.docx" "https://ndownloader.figshare.com/files/34771672"

文件清单

  • DataSheet1_Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carc.docx(1.92 MB)

文件总体积 1.92 MB(源站 API 实测)。

数据说明

Background: Nowadays, although the cause of hepatocellular carcinoma (HCC) mortality and recurrence remains at a high level, the 5-year survival rate is still very low. The DNA damage response and repair (DDR) pathway may affect HCC patients’ survival by influencing tumor development and therapeutic response. It is necessary to identify a prognostic DDR-related gene signature to predict the outcome of patients.
Methods: Level 3 mRNA expression and clinical information were extracted from the TCGA website. The GSE14520 datasets, ICGC-LIRI datasets, and a Chinese HCC cohort were served as validation sets. Univariate Cox regression analysis and LASSO-penalized Cox regression analysis were performed to construct the DDR-related gene pair (DRGP) signature. Kaplan–Meier survival curves and time-dependent receiver operating characteristic (ROC) analysis curves were calculated to determine the predictive ability of this prognostic model. Then, a prognostic nomogram was established to help clinical management. We investigated the difference in biological processes between HRisk and LRisk by conducting several enrichment analyses. The TIDE algorithm and R package “pRRophetic” were applied to estimate the immunotherapeutic and chemotherapeutic response.
Results: We constructed the prognostic signature based on 23 DDR-related gene pairs. The patients in the training datasets were divided into HRisk and LRisk groups at median cut-off. The HRisk group had significantly poorer OS than the LRisk group, and the signature was an independent prognostic indicator in HCC. Furthermore, a nomogram of the riskscore combined with TNM stage was constructed and detected by the calibration curve and decision curve. The LRisk group was associated with higher expression of HBV oncoproteins and metabolism pathways, while DDR-relevant pathways and cell cycle process were enriched in the HRisk group. Moreover, patients in the LRisk group may be more beneficial from immunotherapy. We also found that TP53 gene was more frequently mutated in the HRisk group. As for chemotherapeutic drugs commonly used in HCC, the HRisk group was highly sensitive to 5-fluorouracil, while the LRisk group presented w

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fphar.2022.857060.s001(source: https://frontiersin.figshare.com/articles/dataset/DataSheet1_Identification_of_a_DNA_Damage_Response_and_Repair-Related_Gene-Pair_Signature_for_Prognosis_Stratification_Analysis_in_Hepatocellular_Carcinoma_docx/19573999)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案